Translational Research Institute

Translational Research Institute (TRI) bridges the gap between discovery and care, ensuring scientific breakthroughs are rapidly translated into real-world health outcomes, better treatments, and improved lives. A world leader in translational research, TRI combines the research capability of its four shareholder partners: The University of Queensland, Queensland University of Technology, Mater Research, and Queensland Health. 

TRI accelerates medical research from bench to bedside by bringing together: 
- More than 1,400 researchers, clinicians, industry partners, and corporate teams;
- World-class infrastructure, equipment, and expertise;
- Exceptional clinical trials facilities and an extensive clinical trials network;
- Purpose-built cGMP biomanufacturing facilities and expert wrap-around support.